• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬尿液pH值和尿流量对甲氨蝶呤肾脏清除率的影响(独立因素)

Urinary pH and urine flow independent renal clearance of methotrexate in dogs.

作者信息

Lui C Y, Lee M G, Chiou W L

出版信息

J Pharmacokinet Biopharm. 1985 Apr;13(2):159-71. doi: 10.1007/BF01059396.

DOI:10.1007/BF01059396
PMID:4057055
Abstract

The effects of urine flow and pH on methotrexate renal clearance were studied in seven conditioned male Beagle-Mongrel dogs. Steady-state plasma methotrexate and inulin concentrations were achieved by i.v. infusions preceded by i.v. bolus doses. Plasma and urine concentrations of methotrexate were quantitated by a sensitive high-performance liquid chromatographic assay, while those of inulin were measured by a colorimetric method. Since plasma protein binding of methotrexate was pH and concentration independent, methotrexate/inulin renal clearance without correcting for plasma binding was used for most of the data analyses. The results showed that the renal clearance ratios at the plasma methotrexate levels (approximately 0.1, 1.0, 20.0 and 100 micrograms/ml) studied remained relatively constant when urine pH (differences of up to about 2.5 units) and flow rate (differences of up to approximately 30 times) were changed. This indicated that renal reabsorption of methotrexate in these dogs was negligible. However, concentration-dependent renal clearance was observed. The mean renal clearances were 3.84, 3.94, 2.73, and 2.72 ml/min/kg at plasma concentrations of about 0.1, 1.0, 20.0, and 100.0 micrograms/ml, respectively, when urine was alkalized by sodium bicarbonate. The corresponding clearances were 4.02, 4.28, 2.62,and 2.65 ml/min/kg when urine was acidified by ammonium chloride. These showed the existence of saturable tubular secretion of methotrexate. No 7-hydroxy-methotrexate, a metabolite found in other species, was detected in the urine and plasma of the dogs.

摘要

在7只经条件训练的雄性比格-杂种犬中研究了尿流和pH值对甲氨蝶呤肾清除率的影响。通过静脉推注剂量后进行静脉输注来达到稳态血浆甲氨蝶呤和菊粉浓度。甲氨蝶呤的血浆和尿液浓度通过灵敏的高效液相色谱法进行定量,而菊粉的浓度则通过比色法测量。由于甲氨蝶呤的血浆蛋白结合与pH值和浓度无关,因此在大多数数据分析中使用未校正血浆结合的甲氨蝶呤/菊粉肾清除率。结果表明,在所研究的血浆甲氨蝶呤水平(约0.1、1.0、20.0和100微克/毫升)下,当尿液pH值(相差约2.5个单位)和流速(相差约30倍)发生变化时,肾清除率比值保持相对恒定。这表明这些犬中甲氨蝶呤的肾重吸收可忽略不计。然而,观察到了浓度依赖性肾清除率。当用碳酸氢钠碱化尿液时,在血浆浓度约为0.1、1.0、20.0和100.0微克/毫升时,平均肾清除率分别为3.84、3.94、2.73和2.72毫升/分钟/千克。当用氯化铵酸化尿液时,相应的清除率分别为4.02、4.28、2.62和2.65毫升/分钟/千克。这些结果表明存在甲氨蝶呤的饱和肾小管分泌。在犬的尿液和血浆中未检测到在其他物种中发现的代谢产物7-羟基甲氨蝶呤。

相似文献

1
Urinary pH and urine flow independent renal clearance of methotrexate in dogs.犬尿液pH值和尿流量对甲氨蝶呤肾脏清除率的影响(独立因素)
J Pharmacokinet Biopharm. 1985 Apr;13(2):159-71. doi: 10.1007/BF01059396.
2
Clearance studies of methotrexate in dogs after multiple-rate infusion.多次速率输注后犬体内甲氨蝶呤的清除率研究。
Cancer Res. 1985 Apr;45(4):1545-8.
3
Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
J Pharmacokinet Biopharm. 1984 Dec;12(6):597-610. doi: 10.1007/BF01059555.
4
Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.多次剂量输注后兔体内甲氨蝶呤和7-羟基甲氨蝶呤的清除率研究。
J Pharmacokinet Biopharm. 1983 Oct;11(5):515-27. doi: 10.1007/BF01062209.
5
Renal and non-renal clearances of iothalamate.碘他拉酸盐的肾脏清除率和非肾脏清除率。
Biopharm Drug Dispos. 1986 Jul-Aug;7(4):347-55. doi: 10.1002/bdd.2510070405.
6
Effect of urine pH and flow on renal clearance of methotrexate.尿液酸碱度和流量对甲氨蝶呤肾清除率的影响。
Eur J Clin Pharmacol. 1981;19(6):453-6. doi: 10.1007/BF00548590.
7
[Renal excretion of methotrexate in an in vivo model in minipigs].
Acta Medica (Hradec Kralove) Suppl. 2000;43(2):139-47.
8
Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.犬体内3H标记的环磷酸腺苷和3H标记的环磷酸鸟苷的血浆清除率及肾清除率
J Clin Invest. 1974 Jan;53(1):163-72. doi: 10.1172/JCI107534.
9
Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers.通过静脉推注法测定健康受试者和腹水患者的菊粉清除率:作为肾小球滤过标志物的全身清除率和肾清除率的等效性。
Br J Clin Pharmacol. 1998 Dec;46(6):605-9. doi: 10.1046/j.1365-2125.1998.00824.x.
10
Reassessment of the single intravenous injection method with inulin for measurement of the glomerular filtration rate in man.用菊粉单次静脉注射法重新评估人体肾小球滤过率的测定。
Clin Sci (Lond). 1991 Feb;80(2):167-76. doi: 10.1042/cs0800167.

引用本文的文献

1
Concentration and pH dependent steady-state volume of distribution of methotrexate estimated by a simple physiologically based method.
J Pharmacokinet Biopharm. 1984 Dec;12(6):597-610. doi: 10.1007/BF01059555.
2
Saturable pharmacokinetics in the renal excretion of drugs.药物经肾排泄的饱和药代动力学
Clin Pharmacokinet. 1989 Jan;16(1):38-54. doi: 10.2165/00003088-198916010-00003.

本文引用的文献

1
Sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of methotrexate and its metabolites in plasma, saliva and urine.
J Chromatogr. 1981 Nov 13;226(1):125-34. doi: 10.1016/s0378-4347(00)84213-9.
2
Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storage.甲氨蝶呤在正常人血清中的蛋白结合:药物浓度、pH值、温度及储存的影响
J Pharmacol Methods. 1981 May;5(3):203-13. doi: 10.1016/0160-5402(81)90088-7.
3
Effect of urine pH and flow on renal clearance of methotrexate.尿液酸碱度和流量对甲氨蝶呤肾清除率的影响。
Eur J Clin Pharmacol. 1981;19(6):453-6. doi: 10.1007/BF00548590.
4
Pharmacokinetics of drugs in blood. I. Unusual distribution of gentamicin.药物在血液中的药代动力学。I.庆大霉素的异常分布。
Biopharm Drug Dispos. 1981 Jan-Mar;2(1):89-97. doi: 10.1002/bdd.2510020110.
5
Creatinine XI. Extensive renal tubular reabsorption and secretion in man and its clinical significance.
Res Commun Chem Pathol Pharmacol. 1982 May;36(2):349-52.
6
The significance of the arterial-venous plasma concentration difference in clearance studies.动静脉血浆浓度差在清除率研究中的意义。
Int J Clin Pharmacol Ther Toxicol. 1982 May;20(5):197-203.
7
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia.急性淋巴细胞白血病患儿中剂量甲氨蝶呤的处置情况
Drug Intell Clin Pharm. 1982 Nov;16(11):839-42. doi: 10.1177/106002808201601105.
8
Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.大剂量甲氨蝶呤输注后甲氨蝶呤和7-羟基甲氨蝶呤的药代动力学
Cancer Treat Rep. 1982 Sep;66(9):1733-41.
9
Dependence of renal clearance on urine flow: a mathematical model and its application.
J Pharm Sci. 1983 Feb;72(2):154-8. doi: 10.1002/jps.2600720215.
10
A specific HPLC assay to determine the pharmacokinetics of methotrexate in patients.
Int J Clin Pharmacol Ther Toxicol. 1984 Jan;22(1):1-6.